Literature DB >> 24301521

A FRET-based approach for identification of proteasome catalytic subunit composition.

Ji Eun Park1, Ying Wu, Kimberly Cornish Carmony, Zachary Miller, Lalit Kumar Sharma, Do-Min Lee, Doo-Young Kim, Wooin Lee, Kyung-Bo Kim.   

Abstract

Mammalian cells have two main types of proteasomes, the constitutive proteasome and the immunoproteasome, each containing a distinct set of three catalytic subunits. Recently, additional proteasome subtypes containing a non-standard mixture of catalytic subunits have gained increasing attention, especially due to their presence in cancer settings. However, practical methods for identifying proteasome subtypes have been lacking. Here, we report the development of the first fluorescence resonance energy transfer (FRET)-based strategy that can be utilized to identify different proteasome subtypes present within cells. We have developed FRET donor- and acceptor-probes that are based on previously reported peptide epoxyketones and selectively target individual proteasome catalytic subunits. Using the purified proteasome and cancer cell lysates, we demonstrate the feasibility of a FRET-based approach for determining the catalytic subunit composition of individual 20S proteasome subtypes. Ultimately, this approach may be utilized to study the functions of individual proteasome subtypes in cells.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24301521      PMCID: PMC3898201          DOI: 10.1039/c3mb70471h

Source DB:  PubMed          Journal:  Mol Biosyst        ISSN: 1742-2051


  34 in total

Review 1.  Distance determination in protein-DNA complexes using fluorescence resonance energy transfer.

Authors:  Mike Lorenz; Stephan Diekmann
Journal:  Methods Mol Biol       Date:  2006

Review 2.  20S proteasome and its inhibitors: crystallographic knowledge for drug development.

Authors:  Ljudmila Borissenko; Michael Groll
Journal:  Chem Rev       Date:  2007-02-23       Impact factor: 60.622

3.  Regulation of CD8+ T cell development by thymus-specific proteasomes.

Authors:  Shigeo Murata; Katsuhiro Sasaki; Toshihiko Kishimoto; Shin-Ichiro Niwa; Hidemi Hayashi; Yousuke Takahama; Keiji Tanaka
Journal:  Science       Date:  2007-06-01       Impact factor: 47.728

4.  Mammalian proteasome subpopulations with distinct molecular compositions and proteolytic activities.

Authors:  Oliver Drews; Robert Wildgruber; Chenggong Zong; Ute Sukop; Mikkel Nissum; Gerhard Weber; Aldrin V Gomes; Peipei Ping
Journal:  Mol Cell Proteomics       Date:  2007-07-27       Impact factor: 5.911

Review 5.  Catalytic mechanism and assembly of the proteasome.

Authors:  António J Marques; R Palanimurugan; Ana C Matias; Paula C Ramos; R Jürgen Dohmen
Journal:  Chem Rev       Date:  2009-04       Impact factor: 60.622

6.  Intermediate-type 20 S proteasomes in HeLa cells: "asymmetric" subunit composition, diversity and adaptation.

Authors:  Nicola Klare; Michael Seeger; Katharina Janek; Peter R Jungblut; Burkhardt Dahlmann
Journal:  J Mol Biol       Date:  2007-08-02       Impact factor: 5.469

7.  Multiple cardiac proteasome subtypes differ in their susceptibility to proteasome inhibitors.

Authors:  Alexander Kloss; Silke Meiners; Antje Ludwig; Burkhardt Dahlmann
Journal:  Cardiovasc Res       Date:  2009-06-28       Impact factor: 10.787

8.  The catalytic sites of 20S proteasomes and their role in subunit maturation: a mutational and crystallographic study.

Authors:  M Groll; W Heinemeyer; S Jäger; T Ullrich; M Bochtler; D H Wolf; R Huber
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-28       Impact factor: 11.205

9.  Unexpected role for the immunoproteasome subunit LMP2 in antiviral humoral and innate immune responses.

Authors:  Scott E Hensley; Damien Zanker; Brian P Dolan; Alexandre David; Heather D Hickman; Alan C Embry; Cara N Skon; Kristie M Grebe; Thomas A Griffin; Weisan Chen; Jack R Bennink; Jonathan W Yewdell
Journal:  J Immunol       Date:  2010-03-12       Impact factor: 5.422

10.  Carfilzomib can induce tumor cell death through selective inhibition of the chymotrypsin-like activity of the proteasome.

Authors:  Francesco Parlati; Susan J Lee; Monette Aujay; Erika Suzuki; Konstantin Levitsky; James B Lorens; David R Micklem; Paulina Ruurs; Catherine Sylvain; Yan Lu; Kevin D Shenk; Mark K Bennett
Journal:  Blood       Date:  2009-08-11       Impact factor: 22.113

View more
  5 in total

1.  Elucidating the catalytic subunit composition of distinct proteasome subtypes: a crosslinking approach employing bifunctional activity-based probes.

Authors:  Kimberly Cornish Carmony; Lalit Kumar Sharma; Do-Min Lee; Ji Eun Park; Wooin Lee; Kyung-Bo Kim
Journal:  Chembiochem       Date:  2014-12-04       Impact factor: 3.164

2.  Fluorescent Probes with Unnatural Amino Acids to Monitor Proteasome Activity in Real-Time.

Authors:  Breanna L Zerfas; Rachel A Coleman; Andres F Salazar-Chaparro; Nathaniel J Macatangay; Darci J Trader
Journal:  ACS Chem Biol       Date:  2020-08-26       Impact factor: 5.100

3.  Polymer micelle formulation for the proteasome inhibitor drug carfilzomib: Anticancer efficacy and pharmacokinetic studies in mice.

Authors:  Ji Eun Park; Se-Eun Chun; Derek Reichel; Jee Sun Min; Su-Chan Lee; Songhee Han; Gongmi Ryoo; Yunseok Oh; Shin-Hyung Park; Heon-Min Ryu; Kyung Bo Kim; Ho-Young Lee; Soo Kyung Bae; Younsoo Bae; Wooin Lee
Journal:  PLoS One       Date:  2017-03-08       Impact factor: 3.240

Review 4.  Modelling proteasome and proteasome regulator activities.

Authors:  Juliane Liepe; Herman-Georg Holzhütter; Peter M Kloetzel; Michael P H Stumpf; Michele Mishto
Journal:  Biomolecules       Date:  2014-06-20

Review 5.  Site-Specific Proteasome Inhibitors.

Authors:  Alexei F Kisselev
Journal:  Biomolecules       Date:  2021-12-31
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.